A 22-year-old male presented with a 14-day history of fever and right-sided chest pain that worsened with deep breathing and coughing. On examination, he was febrile and tachycardic with dullness on percussion of the right infraaxillary area and diminished breath sounds. The document discusses various pleural diseases including pneumothorax, pleural effusion, and fibrous pleurisy. It outlines their etiologies, clinical features, investigations, and management. Primary spontaneous pneumothorax commonly affects young, thin males and smokers due to rupture of subpleural blebs. Pleural effusions can be transudative such as in heart failure or exudative including those
The goal of surgical therapy in pulmonary hydatid disease is to remove the cyst while preserving as much lung tissue as possible. The surgical method may be different in the intact (simple) and ruptured (complicated) cysts. The operation has two steps: a) removal of the germinative layer, b) management of the residual pulmonary cavity. Simple cysts are generally removed after needle aspiration or enucleation without needle aspiration.
General principles of the operationThe aim of surgery in pulmonary hydatid cyst is to remove the cyst completely while preserving the lung tissue as much as possible . Lung resection is performed only if there is an irreversible and disseminated pulmonary destruction. Careful manipulation of the cyst and adherence to the precaution to avoid the contamination of the operative field with the cyst content is the imperative part of the operation.
PATHOGENESIS OF BRONCHIECTASIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MED...Prof Dr Bashir Ahmed Dar
Dr Bashir Ahmed Dar associate professor medicine chinkipora sopore kashmir presently working in malaysia speaks about bronchiectasis.Bronchiectasis which is defined as the irreversible dilatation of the cartilage-containing airways bronchi or bronchioles.
Abnormal fluid accumulation in potential space in between parietal and visceral pleurae – there is imbalance between formation and absorption in response to injury, inflammation or both locally and systematically
The goal of surgical therapy in pulmonary hydatid disease is to remove the cyst while preserving as much lung tissue as possible. The surgical method may be different in the intact (simple) and ruptured (complicated) cysts. The operation has two steps: a) removal of the germinative layer, b) management of the residual pulmonary cavity. Simple cysts are generally removed after needle aspiration or enucleation without needle aspiration.
General principles of the operationThe aim of surgery in pulmonary hydatid cyst is to remove the cyst completely while preserving the lung tissue as much as possible . Lung resection is performed only if there is an irreversible and disseminated pulmonary destruction. Careful manipulation of the cyst and adherence to the precaution to avoid the contamination of the operative field with the cyst content is the imperative part of the operation.
PATHOGENESIS OF BRONCHIECTASIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MED...Prof Dr Bashir Ahmed Dar
Dr Bashir Ahmed Dar associate professor medicine chinkipora sopore kashmir presently working in malaysia speaks about bronchiectasis.Bronchiectasis which is defined as the irreversible dilatation of the cartilage-containing airways bronchi or bronchioles.
Abnormal fluid accumulation in potential space in between parietal and visceral pleurae – there is imbalance between formation and absorption in response to injury, inflammation or both locally and systematically
Respiratory Disorders
Disease Condition Pneumothorax, Causes, Sign and Symptoms, Pathophysiology, Types, Assessment and Dignostic Test, Management
By HIREN GEHLOTH For Nursing Students Medical Surgical Nursing
LAUGH A LOT IT CLEARS THE LUNGS
TEACHING IS ONE PROFESSION THAT CREATE ALL OTHER PROFESSION
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
2. CASE SCENARIO
22yr male
C/c – fever x 14 days
Right side chest pain x 14 days
HOPI - High grade fever assoc with right side stabbing chest pain that
is intensified by deep inspiration/cough.
Cough with whitish sputum and 1 episode of hemoptysis 10 days ago
3. On examination
Thin, BMI 19.5 Kg/m2
Febrile - 101ᵒF
PR – 110/mt, BP 96/60mmHg
RR – 30/min
Tenderness on palpation Rt side of chest
Dullness + Rt Infraaxillary area on percussion
Diminished breath sounds in the right infraaxillary area
7. DEFINITION
Inflammation of the pleura characterizedby fibrinous exudation and no
significant degree of effusion.
8. ETIOLOGY
A. Primary pleural disease:
1. Tuberculosis;
2. Rheumatic fever;
3. Viral disease: Coxsackie B virus may cause a recurrent
pleuromyositis, named “Pleurodynia” or “Bernholm disease”;
4. Malignant (mesothelioma).
9. B. Secondary to:
1. Lung disease: pneumonia, tuberculosis, lung abscess or
pulmonary infarction;
2. Mediastinal disease: pericarditis, mediastinitis or
malignancy;
3. Subdiaphragmatic disease: amoebic or subphrenic
abscess.
10. CLINICAL FEATURES
Pleuritic pain ( sudden , stitching chest pain, increasing with inspiration, coughing
and movements)
In diaphragmatic pleurisy, the pain is referred to the shoulder (via phrenic nerve) or
to the epigastrium and lumbar region ( thru lower intercostal nerves)
Pleuritic cough – dry , due to irritation of pleura
Dyspnea – due to :
Restriction of respiratory movements
Underlying lung disease or development of effusion
Specific Etiological and general features : fever, headache and malaise
11. • SIGNS:
1. Inspection
o Limitation of movements on the affected side.
2. Palpation
o Sometimes palpable pleural rub.
3. Percussion
o Tenderness .
4. Auscultation
o PLEURAL RUB
12. Chest X-ray must be performed in every case for detecting a thoracic
cause for the pleurisy.
16. Spontaneous pneumothorax occurs when the visceral pleura ruptures without
an external traumatic or iatrogenic cause.
Primary spontaneous pneumothorax is a disease in its own right.
Secondary spontaneous pneumothorax occurs when the visceral pleura leaks as
part of an underlying lung disease e.g tuberculosis, any degenerative or cavitating
lung disease and necrotising tumours.
17. • Tension pneumothorax is when there is a build-up of positive
pressure within the hemithorax, to the extent that the lung is
completely collapsed, the diaphragm is flattened and the mediastinum
is distorted and, eventually, the venous return to the heart is
compromised.
• Any pleural breach is inherently valve-like because air will find its way
out through the alveoli but cannot be drawn back in because the lung
tissue collapses around the hole in the pleura
18. CLINICAL FEATURES
Symptoms:
Sudden-onset unilateral chest pain ranging from minimal to severe on
the affected side.
Dyspnea occur in nearly all patients.
May present with life-threatening respiratory failure if underlying
diseased lung
19. Signs:
If pneumothorax is small : (<15% of a hemithorax), physical findings are
unimpressive.
If pneumothorax is large: signs of mediastinal shift to opposite side, ↓ed movement,
↓ed tactile fremitus and diminished breath sounds
Tension pneumothorax should be suspected in the presence of marked tachycardia
and hypotension
20. INVESTIGATION
Chest X-ray shows the sharply defined edge of the deflated lung with
complete translucency (no lung markings) between this and the chest
wall
CT Thorax if in doubt
Investigations aimed at finding the cause (e.g. Pulmonary TB, COPD)
21. PRIMARY SPONTANEOUS
PNEUMOTHORAX
Incidence and Patient Demographics:
7.4/100,000/year for males and 1.2/100,000/year for females.
The male-to-female predominance ranges from 6:1 to 3:1.
20 and 40 years of age
Taller and thinner
Occurs almost exclusively in smokers
22. Etiology:
Rupture of subpleural blebs or bullae on the apical portion of the upper lobes
Airway inflammation secondary to cigarette smoking may contribute to the
development of these blebs
Other etiologies include abnormalities of connective tissue (e.g.,Marfan’s syndrome)
Genetic risk factors
23. RECURRENCE:
Approximately one-half of patients
Usually occurs within 1 to 2 years after the first episode.
No predilection for the right or left hemithorax with the initial episode,
75 percent of recurrences occur on the same side as the first
pneumothorax
24. Treatment:
Simple aspiration
If the lung does not expand with aspiration, or if the patient has a recurrent
pneumothorax, thoracoscopy with stapling of blebs and pleural abrasion is indicated.
Thoracoscopy or thoracotomy with pleural abrasion is almost 100% successful in
preventing recurrences.
Prognosis – death is rare
25. SECONDARY SPONTANEOUS
PNEUMOTHORAX
Incidence and Patient Demographics:
6.3/100,000/yr for males and 2.0/100,000/yr for females
Patients with secondary spontaneous pneumothorax are 15 to 20
years older than patients with primary spontaneous pneumothorax.
The risks of recurrence vary from 40 to 80 %
29. TREATMENT
Nearly all patients – treated with tube thoracostomy.
Most should also be treated with thoracoscopy or thoracotomy with the stapling of blebs and
pleural abrasion.
If the patient not a good operative candidate or refuses surgery, then pleurodesis to be done by
intrapleural injection of sclerosing agent such as doxycycline.
30. Prognosis:
In contrast to the low mortality rate in PSP, in patients with SSP, there
is a much higher risk of mortality.
31. TRAUMATIC PNEUMOTHORAX
Trauma is the most common cause of pneumothorax
Both penetrating and nonpenetrating chest trauma
Treatment is tube thoracostomy unless very small. If hemopneumothorax is present,
one chest tube placed in the superior part of the hemithorax to evacuate air, and
another placed in the inferior part of the hemithorax to remove blood.
32. COMPLICATIONS
TENSION PNEUMOTHORAX
Is a pneumothorax in which the pressure in the pleural space is
positive throughout the respiratory cycle.
The mechanism responsible for tension pneumothorax is the disruption
of the parietal pleura in such a manner that a one-way valve happens
33. Can occur after any type of pneumothorax
Independent of etiology
More common after a traumatic pneumothorax, with mechanical ventilation, or during
cardiopulmonary resuscitation
34. CLINICAL PICTURE
The patient will appear acutely ill - Severe dyspnea, Profuse
diaphoresis and cyanosis
On physical examination:
Profound hypotension and hypoxemia
Distended neck veins
Tracheal deviations to the side opposite, Subcutaneous emphysema
Unilateral chest hyperinflation.
35. If tension in pleural space not relieved, pt is likely to die from inadequate cardiac output
or marked hypoxemia
Large-bore needle inserted into pleural space through 2nd anterior ICS. If large amount
of gas escapes from needle, diagnosis – confirmed.
Needle to be left in place till thoracostomy tube can be inserted.
36. RE-EXPANSION PULMONARY EDEMA
Re-expansion pulmonary edema is a rare but potentially lethal
condition that can occur with the rapid re-expansion of a collapsed
lung (after a varied period of time) after tube thoracostomy is used to
drain air (pneumothorax) or fluid (pleural effusion) from the pleural
space.
Bronchopleural fistula
42. MECHANISMS OF PLEURAL FLUID ACCUMULATION
Increased hydrostatic
pressure in the
microvascular circulation
(heart failure)
Decreased oncotic
pressure in the
microvascular circulation
(severe hypoalbuminemia)
Decreased pressure in the
pleural space (lung
collapse)
Increased permeability of
the microvascular
circulation (pneumonia)
Impaired lymphatic
drainage from the pleural
space (malignant effusion)
Movement of fluid from
the peritoneal space
(ascites)
46. CLINICAL FEATURES
Symptoms
Many patients have no symptoms referable to the effusion.
Pleuritic chest pain indicates inflammation of the pleura
Some patients with pleural effusions experience a dull, aching
chest pain rather than pleuritic chest pain. This symptom is very
suggestive that the patient has pleural malignancy.
47. The presence of either pleuritic chest pain or dull, aching chest pain indicates that the
parietal pleura is probably involved and that the patient has an exudative pleural
effusion.
Dry, nonproductive cough. It may be related to pleural inflammation. or lung compression
by the fluid may bring opposing bronchial walls into contact, stimulating the cough reflex.
48. Dyspnea. A pleural effusion acts as a space- occupying process in the
thoracic cavity and therefore reduces all subdivisions of lung volumes.
49. SIGNS
Hemithorax will be larger, usual concavity of intercostal spaces – blunted or
even convex
Tactile fremitus – absent/attenuated (fluid absorbs vibrations emanating from
lung)
Mediastinal shift ( Trachea and apical impulse shift to opp side)
Percussion note – dull
Shifting dullness ( free fluid)
Auscultation : Decreased/absent breath sounds. Pleural rub +/-
50. CLUES TO ORIGIN ??
Cardiomegaly, neck vein distension, or peripheral edema(CHF).
Signs of joint disease or subcutaneous nodules (rheumatoid disease or lupus
erythematosus)
An enlarged, non-tender nodular liver or the presence of hypertrophic osteoarthropathy
suggests metastatic disease, as do breast masses or the absence of a breast.
Abdominal tenderness suggests a sub-diaphragmatic process, whereas tense ascites
suggests cirrhosis
Lymphadenopathy suggests lymphoma, metastatic disease, or sarcoidosis.
51. INVESTIGATIONS
Chest X-ray:
Blunting of the sharp costophrenic angle.
Fluid accumulation between the lung and the diaphragm (subpulmonic effusion) is
suspected if there is apparent elevation of the hemidiaphragm or widening of the
shadow between the gas-containing stomach and the lower left lung margin.
52. Chest X-ray:
Up to 300 mL of fluid may fail to be seen on a PA chest radiograph, whereas as little as
150 mL may be seen on a lateral decubitus view.
A supine film (e.g. in ICU patients) may obscure the diagnosis because the fluid layers
posteriorly.
A pseudotumor occurs when fluid loculates in an interlobar fissure, a clue to the
diagnosis is the presence of pleural fluid elsewhere and a biconvex lenticular
configuration of the mass.
57. PLEURAL EFFUSION.: A, Blood-stained pleural aspirate. This patient
had pleural metastases from carcinoma of the breast.
B, Chylous pleural effusion. This patient had bronchial carcinoma that
had invaded and obstructed the thoracic duct.
C, Pleural transudate. This pale effusion is typically found in patients
with heart failure or other causes of generalized edema.
58.
59.
60. EMPYEMA
• Is pus in the pleural space
Etiology:
• Empyema is always secondary to infection in a neighbouring
structure, usually the lung. The principal infections liable to
produce empyema are the bacterial pneumonias and TB.
62. CLINICAL FEATURES
Symptoms:
• Pyrexia, usually high and remittent
• Rigors, sweating, malaise and weight loss
• Pleural pain
• Breathlessness
• Cough and sputum usually because of underlying
lung disease;
• Copious purulent sputum (bronchopleural fistula)
64. TREATMENT
• Antibiotics OR anti tubercular drugs
• Intercostal tube drainage
• Decortication if gross thickening of the visceral pleura has
developed and is preventing re-expansion of the lung
66. REFERENCES
Harrisons Textbook of Medicine 20th ed
Davidsons’ Principles and Practice of Medicine
Fishman’s Pulmonary Diseases and Disorders 5th ed
Murray and Nadel’s Textbook of Respiratory Medicine 6th ed